Evidence map›Paper›PMID 19200802›Full record

ArticleCell stem cell2009

Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.

Tim C P Somervaille, Christina J Matheny, Gary J Spencer, Masayuki Iwasaki, John L Rinn, Daniela M Witten, Howard Y Chang, Sheila A Shurtleff, James R Downing, Michael L Cleary

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 226 papers.

0numbers the graph read from it
0cells of the map it votes in
226citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

226 citing papers in PubMed, 358 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Epigenetic regulation of cancer stemness.Signal transduction and targeted therapy · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Structure and Functions of HMGB3 Protein.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Transcription Factor MYB as Therapeutic Target: Current Developments.International journal of molecular sciences · 2024
    Review
  18. Article
  19. PHF6 suppresses self-renewal of leukemic stem cells in AML.bioRxiv : the preprint server for biology · 2024
    Article
  20. MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML.Advances in experimental medicine and biology · 2024
    Review

166 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Tim C P SomervailleDepartment of Pathology, Stanford University, Stanford, CA 94305, USA; Cancer Research UK Leukaemia Biology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK.
Christina J Matheny
Gary J Spencer
Masayuki Iwasaki
John L Rinn
Daniela M Witten
Howard Y Chang
Sheila A Shurtleff
James R Downing
Michael L Cleary
Stanford University · USCancer Research UK Manchester Institute · GBUniversity of Manchester · GB

Funding

TUMOR BIOLOGYT32CA009151 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1985 to 2014
$5.5M
Molecular Targeting of MLL and Associated FactorsR01CA116606 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 2005 to 2020
$4.7M
PATHOLOGY AND BIOLOGY OF LEUKEMIA ONCOGENESR01CA055029 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1991 to 2008
$3.1M
Cancer Research UK C147/A6058NCI NIH HHS CA 116606NCI NIH HHS CA 55029NCI NIH HHS R01 CA055029NCI NIH HHS R01 CA116606NCI NIH HHS T32 CA009151NCI NIH HHS T32 CA 09151
6 · The paper itself

Abstract

The genetic programs that promote retention of self-renewing leukemia stem cells (LSCs) at the apex of cellular hierarchies in acute myeloid leukemia (AML) are not known. In a mouse model of human AML, LSCs exhibit variable frequencies that correlate with the initiating MLL oncogene and are maintained in a self-renewing state by a transcriptional subprogram more akin to that of embryonic stem cells (ESCs) than to that of adult stem cells. The transcription/chromatin regulatory factors Myb, Hmgb3, and Cbx5 are critical components of the program and suffice for Hoxa/Meis-independent immortalization of myeloid progenitors when coexpressed, establishing the cooperative and essential role of an ESC-like LSC maintenance program ancillary to the leukemia-initiating MLL/Hox/Meis program. Enriched expression of LSC maintenance and ESC-like program genes in normal myeloid progenitors and poor-prognosis human malignancies links the frequency of aberrantly self-renewing progenitor-like cancer stem cells (CSCs) to prognosis in human cancer.

Indexed as

Transcription, GeneticAnimalsCells, CulturedChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneDisease Models, AnimalEmbryonic Stem CellsGene Expression ProfilingGene Expression Regulation, LeukemicHMGB3 ProteinHumansMiceMice, Inbred C57BLMyeloid-Lymphoid Leukemia ProteinNeoplastic Stem CellsOligonucleotide Array Sequence AnalysisCBX5 protein, humanCBX5 protein, mouseChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHMGB3 ProteinMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionOncogene Proteins v-myb

Identifiers

PMID19200802
PMCPMC2670853
OpenAlexW1970309962

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.